Gardasil vs. Cervarix for HPV Vaccination

Can you choose which one you get?


Joe Raedle / Getty Images News/Getty Image

In This Article

If you or your child is due to get the human papillomavirus (HPV) vaccine—a shot that helps to protect against a variety of HPV strains—you may have heard that there are two brands available: Gardasil and Cervarix.

The two vaccines protect against different strains of HPV (there are hundreds), a virus that is passed from person to person during all types of sexual contact, including intercourse, oral sex, and anal sex, and is linked to several forms of cancer. Not all strains of HPV are associated with these diseases, however, which is why HPV vaccines have been designed to zero in on the ones that are most aggressive—HPV 16 and 18, according to the American Cancer Society.

You may be asking: What's the difference between them and which one is available to you? Read on to learn more about both vaccines.

Making the Choice

Regarding the question of choosing which shot you get, that depends. For a few years, both Gardasil, which is manufactured by the pharmaceutical company Merck, and Cervarix, made by GlaxoSmithKline (GSK), were offered in the United States.

However, Cervarix wasn't able to keep up with Gardasil in terms of sales. So, in late 2016, GSK stopped making it in the U.S. It's still available in other countries, including those that make up Europe, however. Cervarix is also the first and only only HPV vaccine to be approved in China.

So if you live in the US, Gardasil is the only option for you. It's important to note that when you hear the name Gardasil, your doctor is actually referring to Gardasil 9 - the updated version.

In December 2014, the U.S. Food and Drug Administration (FDA) approved a new version of Gardasil 9 protects against nine strains of HPV and was approved by the U.S. Food and Drug Administration (FDA) in December 2014.

Since the quadrivalent form of Gardasil isn't available any longer, the comparisons that follow are of Gardasil-9 and Cervarix.


Strain Protection

The HPV strains it protects against include HPV 6, 11, 16, 19, 31, 33, 45, 52, and 58. The original honed in on HPV 6, 11, 16, and 18; HPV 16 and HPV 18 are the two most aggressive ones, and the only strains that Cervarix is focused on (see below).

One thing to note: There is data to suggest that Gardasil-9 and Cervarix may offer cross-protection against other HPV strains; however, they do not protect against any you already may have been infected with.

Dosing Schedule

Gardasil-9 is given in three separate doses over the course of six months. The second shot is given two months after the first, and the last dose is given four months after that. 

It's important to get all three shots for the vaccine to have maximum efficacy. The HPV vaccine can be given in two doses for younger individuals but is always three doses for anyone older than 14.

Who It's For

On its website, the FDA states that Gardasil-9 is indicated for girls and women ages 9 to 45 to prevent cervical, vulvar, vaginal, and anal cancer, and genital warts caused by HPV types 6 and 11 as well as a number of precancerous lesions.

It's also indicated in boys and men ages 9 through 45 for preventing anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58 as well as genital warts and precancerous anal lesions.

The top public health organizations in the U.S. agree that the earlier the better when is comes to HPV vaccination. Guidelines from the US Centers for Disease Control and Prevention (CDC) recommend routine vaccination at age 11 or 12 years. CDC recommends "catch-up" HPV vaccination (3 doses) for all people through age 26, and only recommends the vaccine for adults aged 27 through 45 years after shared clinical-decision making due to low chances for actual benefit. Meanwhile, updated guidelines from the American Cancer Society recommend routine vaccination beginning at age 9 through 12, catch-up vaccination for all people through age 26, and then recommends against vaccination after age 27. The recommendation against later-in-life vaccination is based on low efficacy in this population and a vaccine shortage that is predicted to last for a while. 


Strain Protection

The HPV strains it protects against includes HPV 16 and 18.

Dosing Schedule

Like Gardasil-9, Cervarix is given in three doses—the second dose one month after the first, and the third dose five months after that. All three shots are necessary to get the most protection.

Who It's For

Cervarix is FDA-approved for girls and women ages 9 to 25 to prevent cervical cancer. 

Safety Issues/Side Effects

One of the issues that often comes up in discussions of any HPV vaccine is whether or not it's safe. All three vaccines can have mild to moderate side effects, such as pain and redness at the injection site as well as headaches, stomachaches, and other full-body symptoms. But otherwise, they're considered to be quite safe.

Although more serious side effects have been reported to the vaccine adverse event reporting system from people who've received the HPV shot, these have been shown to not have been related to the vaccine and any reports of vaccine-linked fatalities appear to be unfounded.

HPV Doctor Discussion Guide

Get our printable guide for your next doctor's appointment to help you ask the right questions.

Doctor Discussion Guide Woman
Was this page helpful?
Article Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Toft L, Tolstrup M, Müller M, et al. Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults. Hum Vaccin Immunother. 2014;10(5):1147–1154. doi:10.4161/hv.27925

  2. American Sexual Health Association. FDA approves a new HPV vaccine.

  3. Dosage and administration for GARDASIL 9. Updated October 2019.

  4. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2019;68:698–702. DOI:

  5. Saslow D, Andrews KS, Manassaram-baptiste D, Smith RA, Fontham ETH. Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation. CA Cancer J Clin. 2020; doi: 10.3322/caac.21616.

  6. Cervarix dosage. Updated January 14, 2019.

  7. Centers for Disease Control and Prevention. Questions about HPV vaccine safety. Updated December 11, 2019.

Additional Reading